END-TO-END CELL THERAPY AUTOMATION

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20240052311A1
SERIAL NO

18496573

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure provides an automated method of producing genetically modified immune cells, including chimeric antigen receptor T (CAR T) cells, utilizing a fully-enclosed cell engineering system.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
LONZA COLOGNE GMBHNATTERMANNALLEE 1 50829 COLOGNE COLOGNE

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
ABRAHAM, Eytan Walkersville, US 33 154
BANDAPALLE, Samatha Walkersville, US 14 68
GLEISSNER, Timo Cologne, DE 19 71
MCAFEE, Erika Walkersville, US 12 65
O'CONNOR, Joseph Walkersville, US 19 127
PURPURA, Kelly Kingston, CA 8 63
SHI, Yaling Walkersville, US 33 331
SIEHOFF, Ann Cologne, DE 7 56
SMITH, Timothy Kingston, CA 149 2025
TRAINOR, Nuala Kingston, CA 13 67

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation